HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 232 filers reported holding HORIZON PHARMA PLC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $826,000 | -97.7% | 69,606 | -97.1% | 0.05% | -97.2% |
| Q1 2017 | $35,611,000 | +1.0% | 2,409,396 | +10.6% | 1.78% | +9.6% |
| Q4 2016 | $35,248,000 | -6.9% | 2,178,491 | +4.4% | 1.62% | -11.0% |
| Q3 2016 | $37,849,000 | +5.0% | 2,087,636 | -4.6% | 1.82% | +4.1% |
| Q2 2016 | $36,036,000 | +5.1% | 2,187,994 | +5.8% | 1.75% | +10.5% |
| Q1 2016 | $34,278,000 | +0.6% | 2,068,654 | +31.6% | 1.58% | +11.8% |
| Q4 2015 | $34,061,000 | +13.8% | 1,571,794 | +4.1% | 1.42% | +15.5% |
| Q3 2015 | $29,935,000 | -46.8% | 1,510,340 | -6.7% | 1.23% | -40.1% |
| Q2 2015 | $56,247,000 | +38.6% | 1,619,074 | +3.6% | 2.05% | +32.3% |
| Q1 2015 | $40,589,000 | +87.4% | 1,562,904 | -7.0% | 1.55% | +75.4% |
| Q4 2014 | $21,656,000 | +106.9% | 1,680,044 | +97.1% | 0.88% | +102.8% |
| Q3 2014 | $10,469,000 | – | 852,530 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |